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Osteoarthritis (OA) is a progressive joint disease that is strongly associated with
calcium-containing crystal formation (mineralization) by chondrocytes leading ultimately
to cartilage calcification. However, this calcification process is poorly understood and
treatments targeting the underlying disease mechanisms are lacking. The CD11b/CD18
integrin (Mac-1 or αMβ2), a member of the beta 2 integrin family of adhesion receptors,
is critically involved in the development of several inflammatory diseases, including
rheumatoid arthritis and systemic lupus erythematosus. We found that in a collagen-
induced arthritis, CD11b-deficient mice exhibited increased cartilage degradation
compared to WT control animals. However, the functional significance of CD11b integrin
signaling in the pathophysiology of chondrocytes remains unknown. CD11b expression
was found in the extracellular matrix and in chondrocytes in both healthy and damaged
human and murine articular cartilage. Primary murine CD11b KO chondrocytes showed
increased mineralization when induced in vitro by secondary calciprotein particles (CPP)
and quantified by Alizarin Red staining. This increased propensity to mineralize was
associated with an increased alkaline phosphatase (Alp) expression (measured by
qRT-PCR and activity assay) and an enhanced secretion of the pro-mineralizing IL-6
cytokine compared to control wild-type cells (measured by ELISA). Accordingly, addition
of an anti-IL-6 receptor antibody to CD11b KO chondrocytes reduced significantly
the calcification and identified IL-6 as a pro-mineralizing factor in these cells. In the
same conditions, the ratio of qRT-PCR expression of collagen X over collagen II,
and that of Runx2 over Sox9 (both ratio being indexes of chondrocyte hypertrophy)
were increased in CD11b-deficient cells. Conversely, the CD11b activator LA1 reduced
chondrocyte mineralization, Alp expression, IL-6 production and collagen X expression.
In the meniscectomy (MNX) model of murine knee osteoarthritis, deficiency of CD11b
led to more severe OA (OARSI scoring of medial cartilage damage in CD11b: 5.6 ± 1.8,
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in WT: 1.2 ± 0.5, p < 0.05, inflammation in CD11b: 2.8 ± 0.2, in WT: 1.4 ± 0.5).
In conclusion, these data demonstrate that CD11b signaling prevents chondrocyte
hypertrophy and chondrocyte mineralization in vitro and has a protective role in models
of OA in vivo.
Keywords: CD11b, integrin, calcium-containing crystals, osteoarthritis, animal model, chondrocyte
mineralization, cartilage calcification, human cartilage
INTRODUCTION
Osteoarthritis (OA) is a long-term chronic degenerative and
disabling joint disease (Sen and Hurley, 2020) for which no
effective curative disease modifying treatment is available.
A wide range of current treatments only lessen the symptom but
not the underlying condition. Understanding the pathological
mechanisms and the signaling pathways controlling OA
development and progression could provide novel targets that
would improve the treatment of this disorder (Huang et al., 2018;
Kim et al., 2018).
OA is characterized by progressive loss of articular cartilage,
osteophyte formation, synovial inflammation and calcification
in joint structures such as cartilage (Ea et al., 2011; Loeser
et al., 2012; Frallonardo et al., 2018; Yan et al., 2020). Calcium-
containing crystals, which encompass basic calcium phosphate
(BCP) and calcium pyrophosphate dihydrate crystals (CPPD),
have been demonstrated to be of etiologic importance in
OA. Indeed they were shown to actively trigger inflammatory,
catabolic and oxidant responses in joint cells such as synovial
fibroblasts, macrophages, osteoclasts and chondrocytes (Fuerst
et al., 2009; Nasi et al., 2016b; Bertrand et al., 2020; Yan
et al., 2020). However, the receptors and signaling pathways
modulating ectopic calcification in OA joints only start to be
elucidated (Castelblanco et al., 2020).
Cell-surface receptors, such as integrins, mediate interaction
between chondrocytes and the extracellular matrix (ECM)
components, orchestrating its physiological turn-over. Integrins
are composed of different combinations of α- and β-subunits,
most of which have been found expressed in chondrocytes. In
joint physiology, integrins have been demonstrated to play key
roles in chondrogenic differentiation (Varas et al., 2007; LaPointe
et al., 2013; Song and Park, 2014) and chondrocyte survival
(Loeser, 2014). In joint pathology, lack of integrin signaling
has shown to mediate the catabolic reactions responsible for
cartilage matrix degradation, ultimately leading to OA (Lapadula
et al., 1997; Forsyth et al., 2002; Almonte-Becerril et al.,
2014; Loeser, 2014; Tian et al., 2015). For instance, mice
deficient in β1 integrins exhibit disorganized articular cartilage,
reduced mobility and increased OA changes (Raducanu et al.,
2009). On the other hand, cartilage ECM components such as
fibronectin and collagens, are known ligands of integrins. In
fact, Forsyth et al. have reported that α5β1 integrin mediates
matrix degradation induced by fibronectin fragments in cultured
chondrocytes (Forsyth et al., 2002).
CD11b/CD18 (Mac-1 or αMβ2) is a member of the beta 2
integrin family of adhesion receptors (Rosetti and Mayadas, 2016;
Schittenhelm et al., 2017). CD11b serves as a signaling regulator
and its deficiency has been implicated in the development of
inflammatory diseases, such as systemic lupus erythematosus
(SLE), lupus nephritis and rheumatoid arthritis (Ehirchiou et al.,
2007; Reed et al., 2013; Stevanin et al., 2017; Khan et al.,
2018). In SLE, genetic variants in the human ITGAM gene,
which encodes for CD11b, have been strongly associated with
susceptibility to the disease (Nath et al., 2008). Furthermore,
Dahdal et al. (2018) have reported a positive correlation between
disease activity and serum calcification-propensity, as measured
by a novel functional blood test (T50) that is able to measure the
time for spontaneous formation of crystalline calcium phosphate
deposits. It has also been revealed that CD11b is involved in
MyD88/TRIF pathway in SLE, by decreasing IFN-α,β and NF-κB
transcribed cytokines, namely interleukin-6 (IL-6) (Faridi et al.,
2017), which can promote calcium-containing crystal formation
(Nasi et al., 2016b). An additional evidence of the effect of CD11b
on reducing the pro-mineralizing IL-6, is in a mouse model of
collagen-induced arthritis, where our laboratory reported that
CD11b KO mice exhibited higher IL-6 serum levels as compared
with those of WT control animals (Stevanin et al., 2017).
However, the role of CD11b integrin in calcification has not
yet been examined. Based on these observations, we hypothesized
that CD11b integrin signaling might be involved in the process
of cartilage calcification. Here, we found that both murine and
human chondrocytes expressed CD11b integrin. Furthermore,
our results indicate that CD11b deficiency in chondrocytes
disrupted articular cartilage homeostasis by enhancing
chondrocytes calcification, via increased IL-6 production
and a switch toward hypertrophic cell differentiation, overall
leading to cartilage degradation. Finally, our results identified
a newly CD11b-dependent pathway that may be a target in the




Articular chondrocytes were isolated from C57BL/6J and CD11b
KO mice as described previously (Nasi et al., 2016a). Cells were
cultured at a density of 3.5 × 104 cells/cm2 for 7 days in
complete DMEM (10% fetal bovine serum (FBS), 1% Penicillin
Streptomycin). Medium was changed every 2–3 days. Cells
were detached with trypsin-EDTA (Amimed) and counted for
stimulation experiments, all performed in complete DMEM
medium, with LA1 20uM (ChemBridge) dissolved in dimethyl
sulfoxide (DMSO) or equivalent quantity of the vehicle as
control, added 30 min before the mineralization experiment.
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Chondrocytes were stimulated with secondary calciprotein
particles (CPP) for 4, 6, or 24 h, or in BGjb medium (10% FBS,
1% Penicillin Streptomycin) with 50 µg/mL ascorbic acid and
20 mM β-glycerol phosphate for 14 days. Cell monolayers were
stained with Mmp13 rabbit polyclonal antibody (Abcam 39012)
and quantified by ImageJ as percentage of positively stained cells
over total cells in each field. Chondrocytes were stimulated with
10 µg/ml rat anti-mouse IL-6R (15A7, Bio X Cell) monoclonal
antibody or irrelevant IgG2b antibody control.
Calciprotein Particles Preparation
CPP were generated by preparing 20 ml DMEM containing 10%
FBS, 1 mmol/L CaCl2, 3.5 mmol/L inorganic phosphate
(1.36 mmol/L NaH2PO4 and 2.14 mmol/L Na2HPO4)
(Aghagolzadeh et al., 2016). After 7 days incubation at 37◦C, the
suspension was centrifuged for 3 h at 4500 rpm and 4◦C, and
the pellet containing CPP was resuspended in 1 ml DMEM and
stored at−20◦C.
LDH Measurement
Measurement of lactate dehydrogenase (LDH) as a means of
cytotoxicity assay was performed with using CytoTox-ONE
Homogeneous Membrane Integrity Assay (Promega) according
to the manufacturer’s instructions. Values were calculated as
percentage of cytotoxicity using the following formula: LDH
release (%) = [(value in sample) — (background)]/[(value in
Triton X-100-treated sample) — (background)] x100.
Crystal Detection From Chondrocyte
Cultures
Chondrocytes were treated with CPP (50 µg/ml calcium) for
24 h or calcifying medium for 24 h, then washed in PBS and
fixed in 10% formaldehyde. Crystals were quantified with Alizarin
Red staining with Adobe R© Photoshop R© after image binarization
and related pixel counts. Calcium content was quantified by the
QuantiChromTM Calcium Kit (BioAssay Systems) by reading
absorbance at 612 nm using the Spectramax M5e reader
(Molecular Devices).
ELISA Measurements
Supernatants were collected from stimulation experiments, and
assayed using murine or human IL-6 and murine MCP-1 ELISA
kits (eBioscience) following the manufacturer’s protocol. Results
were read at 450 nm by Spectramax M5e (Molecular devices).
Synovial fluid was obtained from 24 OA patients at time of
joint replacement (average age 69 years old ± 10), and CD11b
evaluated in these biological samples by human CD11b ELISA
(LSBio, LifeSpan BioSciences, Inc.).
Real Time Quantitative PCR Analysis
Cells were treated with TRIzol (500 µl for 1 million cells)
and RNA was extracted (RNA Clean and Concentrator
5-Zymoresearch) and reverse transcribed (Superscript II-
InvitrogenTM). Quantitative Real Time PCR (qRT-PCR)
was performed with gene specific primers (Table 1) using
the LightCycler R© 480 system (Roche Applied Science).
Normalization was performed against Gapdh reference gene, and
fold increase of transcripts was calculated against control cells.
Alkaline Phosphatase Activity Assay
Cells were lysed in 0.01% sodium dodecyl sulfate (SDS)
and alkaline phosphatase (Alp) activity was measured
by use of p-Nitrophenyl Phosphate assay (Alkaline
Phosphatase Assay Kit, Abcam, ab83369). Lysate was read
at 405 nm by spectrophotometric measurement (Spectramax
M5e plate reader).
Fluorescence-Activated Cell Staining
Flow cytometry was used to assess CD11b expression on
chondrocytes. Cells were harvested from confluent cultures by
treatment with a non-enzymatic cell dissociation buffer (5 mM
EDTA, 20 mM HEPES in PBS). Cells were re-suspended in
fluorescence-activated cell sorting (FACS) buffer (3% fetal calf
serum, 5 mM EDTA in PBS) and incubated with PE anti-CD11b
(M1/70, eBioscience), FITC anti-CD45 (30-F11, eBioscience)
and FITC anti-F4/80 (BM8, eBioscience) for 30 min at 4◦C
in the dark. For intracellular staining, cells were permeabilized
with Cytofix/Cytoperm solution (BD Biosciences) for 20 min
and then incubated with biotin anti-Collagen II (2B1.5, Abcam)
followed by a streptavidin APC conjugate antibody. Flow
cytometric analyses were performed on LSRII cytometer using
FACS Diva6 (Becton Dickinson) and FlowJoX software for data
processing. The Imaging flow cytometry was carried out with
the ImageStream R©X Mark II Imaging Flow Cytometer (Merck
Millipore, Billerica, MA, United States) using INSPIRE software.
For data evaluation, IDEAS software version 6.0 was used.
Proliferation rate of WT and CD11b KO chondrocyte were
analyzed by FACS after 3 days of culture by using Cell
Proliferation Dye eFluorTM 670 (Invitrogen).
Mice and Induction of Experimental
Osteoarthritis
CD11b KO mice (C57BL/6J background) were provided by
Prof. Britta Engelhardt (Theodor Kocher Institute, University
of Bern). C57BL/6J purchased from Charles River were used as
control mice. All animals were kept in a temperature-controlled
environment in a ventilated rack with a 12:12-h light:dark cycle.
Food and water were given ad libitum.
Control wild-type (WT) and CD11b KO female mice were
anesthetized at 12 weeks of age and knee joint instability was
induced surgically by partial medial meniscectomy (MNX) of
the right knee, and the contralateral knee was sham-operated
as control (Kamekura et al., 2005). Animals were sacrificed
2 months after surgery. For the aging model, control WT
and CD11b KO mice were sacrificed at 37 weeks of age.
For all experimental settings, knees dissected and fixed in
10% formaldehyde.
MicroCT-Scan
Scanning of mice knees was performed with a SkyScan 1076
X-ray µCT scanning system (SkyScan, Belgium), as previously
described (Nasi et al., 2016b). New crystal formations were
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TABLE 1 | Gene primers (forward and reverse) sequences for RT-qPCR analysis (m, murine; h, human).
Primer gene Forward primer (5′ → 3′) Reverse primer (3′ → 5′)
mSox9 AAG ACT CTG GGC AAG CTC TGG A TTG TCC GTT CTT CAC CGA CTT CCT
mColl2 ACA CTT TCC AAC CGC AGT CA GGG AGG ACG GTT GGG TAT CA
mRunx2 GGG AAC CAA GAA GGC ACA GA TGG AGT GGA TGG ATG GGG AT
mColl10 AAA CGC CCA CAG GCA TAA AG CAA CCC TGG CTC TCC TTG G
mAnk TGT CAA CCT CTT CGT GTC CC GAC AAA ACA GAG CGT CAG CG
mAnx5 CCT CAC GAC TCT ACG ATG CC AGC CTG GAA CAA TGC CTG AG
mPit1 CTC TCC GCT GCT TTC TGG TA AGA GGT TGA TTC CGA TTG TGC
mPit2 AAA CGC TAA TGG CTG GGG AA AAC CAG GAG GCG ACA ATC TT
mPC1 CTG GTT TTG TCA GTA TGT GTG CT CTC ACC GCA CCT GAA TTT GTT
mAlp TTG TGC CAG AGA AAG AGA GAG A GTT TCA GGG CAT TTT TCA AGG T
mAdamts4 GCC CGA GTC CCA TTT CCC GC GCC ATA ACC GTC AGC AGG TAG CG
mAdamts5 GAC AGA CCT ACG ATG CCA CCC AGC ATG AGC GAG AAC ACT GAC CCC AGG
mMmp3 ATA CGA GGG CAC GAG GAG AGA AGT AGA GAA ACC CAA ATG CT
mMmp13 GCA GTT CCA AAG GCT ACA AC GCT GGG TCA CAC TTC TCT G
mTimp1 CCC ACA AGT CCC AGA ACC GCA G GCA GGC AAG CA AGT GAC GGC
mTimp3 TCC TAG ACC CAG TTC CAT ATA CAC TTC TTG GAC TTC TGC CAA TT CCT T
mCD11b CTC TTC TGG TCA CAG CCC TA GGG GGA CAG TAG AAA CAG CC
mCD18 AGA CAC AAC CAC ACA GCC AG CCC AGG AAG AAC AGT CCA GC
mGapdh CTC ATG ACC ACA GTC CAT GC CAC ATT GGG GGT AGG AAC AC
hCD11b ATG TCC AGA AGA GCA CAC GG AGG GTC TCA CAA GTC TGG GT
hCD18 GCT GGT GTT TGC CAC TGA TG TCG GTG AGT TTC TCG TAG GTC
hGapdh GAT TTG GTC GTA TTG GGC CTC GCT CCT GGA AGA TGG
quantified by tissue volume (mm3), its bone mineral density
(BMD, g/cm3) and its crystal content (µg). Tibial subchondral
bone was analyzed as means of bone mineral density (BMD,
g/cm3) and trabecular thickness (Tb.Th, mm).
Mouse Knee Histology and
Immunohistochemistry
Fixed knees were decalcified in 5% formic acid, dehydrated,
and embedded in paraffin. Frontal sections of 6 µm at different
deepness of cartilage were stained with Safranin-O-fast green.
OARSI scoring of medial tibial plateau and medial femoral
condyle was performed (score from 0 to 6 for each, in which
0 represents a healthy cartilage; 0.5 is some loss of safranin-O
staining, meaning loss of proteoglycans; 1 some fibrillations in
the superficial layer and no loss of cartilage; 2 erosion of the
surface; 3 to 5 represent various percentages of the deepness of
the cartilage affected by vertical clefts and erosion) (Glasson et al.,
2010). Furthermore, inflammation of the synovial membrane
was scored (each deepness of the sections was scored on a 0
to 3 scale of inflammation, then the average was calculated
for one sample). Paraffin-embedded knee sections were stained
with CD11b antibody (133357, Abcam). MMP13 was detected
with anti-MMP13 (Ab39012 from Abcam), and quantified by
calculating positive cells by use of Image J (U. S. National
Institutes of Health, Bethesda, MD, United States).
Human Cartilage Explants Preparation
and Chondrocytes Isolation
Cartilage explants were obtained from 13 human OA patients
undergoing total knee replacement surgery from Lausanne
University Hospital, Switzerland (average age 71 years old± 11).
Sections of macroscopically undamaged and damaged cartilage
were dissected from the femoral condyles and processed for
histological analysis from 3 patients. The rest of undamaged
and damaged cartilage was cut in small pieces, washed twice
with PBS and twice with DMEM. Cartilage was degraded for
10 h in 10% Liberase (Roche) DMEM, and digested tissue
passed through a 70 µm filter (BD biosciences) to obtain
articular chondrocytes. Cells were plated and cultured as
described above.
Statistical Analysis
All values are expressed as the mean ± SD. Variation between
data sets was evaluated using the Student’s t-test or one-way
or two-way ANOVA test, where appropriate. Differences were
considered statistically significant for a value of p < 0.05
(∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
Data was analyzed with GraphPad Prism software (GraphPad
software), San Diego, CA.
Ethics Statement
Experiments on mice were performed in strict accordance to
the Swiss Federal Regulations. The protocol was approved by
the “Service de la consommation et des affaires vétérinaires
du Canton de Vaud,” Switzerland. All efforts were made to
minimize suffering and minimize the number of mice needed
to assess statistical significance and experimental reproducibility.
Human samples were obtained with the approval of the Centre
Hospitalier Universitaire Vaudois ethical committee and patients’
written informed consent.
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RESULTS
CD11b Integrin Is Expressed in Murine
and Human Articular Cartilage
To determine the distribution of CD11b expression in the
mouse cartilage, CD11b immunostaining was performed on
knee sections from WT and CD11b KO mice. As seen in
Figure 1A (left panels), positive signal was primarily detected
in chondrocytes in the superficial layer of cartilage both in
healthy and meniscectomized WT knee joints (MNX). Verifying
specificity of the antibody, no CD11b staining was detected
in articular chondrocytes of CD11b KO mice (Figure 1A,
top right panel).
This data was confirmed by flow cytometry analysis. Indeed,
3–4% of WT primary chondrocytes extracted from articular
cartilage expressed the CD11b integrin subunit (Figure 1B
and Supplementary Figure 1D). Combining high-resolution
microscopy and FACS (Amnis analysis), we found that CD11b
positive cells also expressed collagen II, a specific marker of
chondrocytes (Figure 1C). In addition, the chondrocytes showed
no expression of F4/80, a macrophage marker (Supplementary
Figure 1D) and were negative for CD45 (Supplementary
Figure 1E), an antigen used to define leukocyte populations.
Furthermore, CD11b expression in murine chondrocytes was
demonstrated by q-PCR (Supplementary Figure 1A).
We next analyzed if CD11b was expressed in human cartilage
by CD11b immunostaining analysis. Cartilage was obtained
from the knee joint of three OA patients and separated into
macroscopically healthy and damaged cartilages. The results
in Figure 1D and Supplementary Figure 1C showed that
CD11b was present in chondrocytes in the superficial layer of
human articular cartilage (black arrows). Interestingly, a diffuse
expression pattern of CD11b at the extracellular matrix was also
observed in the damaged cartilage (red arrows). In Figures 1E,F,
CD11b expression in human chondrocytes was confirmed by
flow cytometry analysis, with an expression level varying from
2 to 6% of the cells. Further proof of CD11b expression by
human chondrocytes was obtained by qPCR (Supplementary
Figure 1B), showing both CD11b and CD18 expression, with
a predominant expression of CD18. We hypothesized that
extracellular matrix deposited CD11b could result from shedding
of the integrin (Gomez et al., 2012). Indeed, we detected by ELISA
measurement soluble CD11b in human OA synovial fluid (24
patients, average 4.5 ng/ml± 0.4).
CD11b Deficiency Increases
Mineralization by Murine Joint
Chondrocytes
We then evaluated the effect of CD11b deficiency on chondrocyte
mineralization. Primary murine chondrocytes were allowed to
mineralize in the presence of calciprotein particles (CPP) and
mineralization was assessed after 24 h by Alizarin Red. As shown
in Figure 2A, CD11b KO chondrocyte culture exhibited massive
calcium containing crystal deposits compared to WT control (in
red). Quantification of Alizarin Red staining showed a 3-fold
significant increase of crystals in CD11b KO cells (Figure 2B).
The increased calcifying ability of CD11b KO chondrocytes
was not restricted to the model used, as we obtained similar
results with another model of calcification (complete medium
with 50 µg/mL ascorbic acid and 20 mM β-glycerol phosphate
for 14 days), i.e., CD11b KO chondrocytes mineralized more
compared to WT control (Supplementary Figure 2A). This effect
was not due to cytotoxicity, as measured by lactate dehydrogenase
(LDH) activity (Supplementary Figure 2B).
To characterize how CD11b might interfere with calcification
in chondrocyte cultures, we assessed changes in the expression
of genes involved in the calcification process (Ea et al., 2011)
(Ank, Anx5, Pit1, Pit2, Pc1 and Alp) by qRT-PCR. Results
in Figure 2C show that Ank, Pit1 and Alp expression were
significantly increased in CD11b KO chondrocytes both in
unstimulated or calcifying conditions (CPP). Regarding Pit2
and Pc1, no significant differences were observed. We provided
further confirmation of the calcifying phenotype of CD11b KO
cells by measuring the activity of alkaline phosphatase (Alp) in
the cell lysate in non-treated and CPP treated chondrocytes. The
Alp specific activity was higher in CD11b KO cells compared
to that of WT control (Figure 2D). Altogether, these results
demonstrate that CD11b deficiency in chondrocytes enhanced
the expression of calcification genes.
CD11b Deficiency Increases Secretion of
the Pro-mineralizing IL-6 Cytokine by
Murine Chondrocytes
We previously demonstrated that IL-6 had pro-mineralizing
effects in chondrocytes and, reciprocally, BCP crystals increased
IL-6, thus leading to a vicious circle (Nasi et al., 2016b). Hence,
we speculated that increased IL-6 secretion by CD11b-deficient
chondrocytes could favor mineralization. Indeed, we detected by
ELISA increased IL-6 levels in the medium from CD11b KO
chondrocytes stimulated with CPP (Figure 2E). Additionally,
CPP stimulation significantly increased MCP-1 secretion in
CD11b deficient chondrocytes compared to WT control. Next,
to understand if IL-6 secretion by CD11b KO chondrocytes was
the main calcification inducer in these cells, we added anti IL-6
receptor antibody and CPP on WT and CD11b KO chondrocytes
(Figure 2F). Indeed, by blocking IL-6 signaling in CD11b KO
cells, the effect on calcification was abrogated and restored
to WT levels, as confirmed by quantification in Figure 2G.
Therefore, deficiency of CD11b in chondrocytes enhances the
pro-inflammatory molecules IL-6 and MCP-1, sustaining the
loop between inflammation and calcification.
CD11b in Chondrocytes Regulates
Genes Involved in Hypertrophy and
Extracellular Matrix Degradation
In order to investigate the mechanisms underlying the effects
of CD11b integrin on extracellular matrix degradation in vitro,
we analyzed the gene expression level of key catabolic factors
in WT and CD11b KO chondrocytes after 4 h exposure to
CPP and their non-treated controls. We focused our analysis
on metalloproteases (Adamts4, Adamts5, Mmp3, Mmp13)
and inhibitors of metalloproteases (Timp1, Timp3), whose
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FIGURE 1 | CD11b integrin is expressed in murine and human articular cartilage. (A) CD11b immunohistochemical staining (brown) in knee cartilage from healthy
WT and CD11b KO mice, and meniscectomized (MNX) WT mice. For each group, one representative picture from one out of 3 mice is shown. Scale bars 50 µm.
(B) FACS analysis and quantification of CD11b positive and Col2 positive primary murine chondrocytes, and (C) Amnis FACS analysis of CD11b positive (green) and
Col2 positive (purple) staining; ****p < 0.0001. (D) CD11b immunohistochemical staining (brown) in undamaged and damaged femoral knee cartilage from OA
patients undergoing joint replacement (black arrows indicate intracellular CD11b expression, red arrows indicate extracellular CD11b expression). For each group,
one representative picture from one (P13) out of 3 patients is shown. Scale bars 100 and 50 µm. (E,F) Flow cytometry analysis of CD11b and Col2 expression on
primary human chondrocytes obtained from cartilage of 5 osteoarthritis patients.
expression plays a major role in chondrocyte extracellular matrix
degradation during OA (Tseng et al., 2009; Troeberg and Nagase,
2012; Roughley and Mort, 2014). As shown in Figure 3A, CD11b
KO chondrocytes, with or without stimulation with CPP, showed
significantly higher levels of Adamts4 and Timp3 mRNA than in
control WT chondrocytes. While Timp1, Adamts5, and Mmp13
mRNA had no significant changes, there was lower Mmp3 in
CD11b KO chondrocytes.
Following expression level analysis, we investigated the
presence of Mmp13 by immunohistochemistry (Figure 3B,
left). Mmp13 was significantly lowered in CD11b deficient
chondrocytes, as confirmed by Image J quantification (Figure 3B,
graph on the right).
We then analyzed, by qPCR, markers of articular cartilage
hypertrophy including early differentiation Sox9 and Col2, and
hypertrophy markers Runx2 and Col10 (Figure 3C). The ratio
calculated on Col10 over Col2 and Runx2 over Sox9 revealed an
increase in hypertrophic phenotype in CD11b KO chondrocytes,
both at basal level and in CPP treated condition. Finally we
ruled out that chondrocyte proliferation was affected by CD11b
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 December 2020 | Volume 8 | Article 611757
fcell-08-611757 December 14, 2020 Time: 19:26 # 7
Ehirchiou et al. CD11b Modulates Cartilage Calcification and Osteoarthritis
FIGURE 2 | CD11b deficiency increases mineralization by murine articular chondrocytes. (A) Alizarin Red staining of WT and CD11b KO primary murine
chondrocytes stimulated with secondary CPP for 24 h in DMEM + 10% FBS. Pictures show one representative culture well of one experiment out of three
independent experiments. Scale bars 1000 µm. (B) The graph shows the percentage of Alizarin Red positive surface over total surface, calculated in Adobe R©
Photoshop R© and normalized on WT chondrocytes. Values represent means ± SD of triplicates samples from one representative experiment out of three independent
experiment; **p < 0.01. (C) qRT-PCR of the indicated genes in primary murine chondrocytes stimulated or not with secondary CPP for 4 h. Values represent fold
increase of CD11b KO chondrocytes over their WT control cells (dotted line), shown in means ± SD of triplicates samples; **p < 0.01, ****p < 0.0001.
(D) Quantification of Alkaline phosphatase activity in WT and CD11b KO primary murine chondrocytes treated or not with secondary CPP for 6 h. Values represent
fold increase of Alp activity in CD11b KO over WT NT cells (dotted line) as means ± SD of triplicates samples; *p < 0.05, **p < 0.01. (E) IL-6 and MCP-1
concentration in cell supernatants of WT and CD11b KO primary murine chondrocytes of point (A). Values represent means ± SD of triplicates samples; **p < 0.01,
***p < 0.001. (F) Alizarin Red staining of WT and CD11b KO murine chondrocytes stimulated with secondary CPP for 24 h in DMEM + 10% FBS and treated or not
with an anti-IL-6 receptor (aIL-6R, 10 µg/ml) or its IgG control (Ctrl, 10 µg/ml). Scale bars 1000 µm. (G) The graph shows the percentage of Alizarin Red positive
surface over the total surface, calculated in Adobe R© Photoshop R© and normalized on control WT chondrocytes. Values represent means ± SD of triplicates samples;
*p < 0.05, **p < 0.01.
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FIGURE 3 | CD11b deficiency in chondrocytes alters the expression of matrix-degrading enzymes and is associated with a pro-hypertrophic expression profile.
(A) qRT-PCR of the indicated genes in WT and CD11b KO primary murine chondrocytes at basal level (left graph) or in cell stimulated with CPP for 4 h (right graph).
Values represent fold increase of CD11b KO chondrocytes over their WT control cells, shown in means ± SD of triplicates samples; *p < 0.05, **p < 0.01,
****p < 0.0001. (B) Mmp13 immunohistochemical staining (brown) in primary murine chondrocytes from WT and CD11b mice. For each group, one representative
picture out of triplicates wells is shown. Scale bars 50 µm. The graph shows quantification of Mmp13 expression calculated as the percentage of positive cells in
each field. Three fields were scored for each triplicate wells and means ± SD plotted; *p < 0.05. (C) qRT-PCR of the indicated genes in WT and CD11b KO primary
murine chondrocytes at basal level (left graph) or in cells stimulated with CPP for 4 h (right graph). Values represent the ratio between late-stage hypertrophic
differentiation markers over early-stage differentiation genes.
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deficiency, as the proliferation response of isolated WT and
CD11b KO chondrocytes by FACS using dye dilution assays for
cell proliferation was similar (Supplementary Figure 2C).
Targeting CD11b With LA1 Agonist
Results in Reduced Murine and Human
Chondrocytes Calcification in vitro
It has been reported that treatment with CD11b agonist LA1
led to integrin activation and suppression of inflammation in
macrophages (Faridi et al., 2017). Given the relationship between
inflammation and chondrocyte calcification, we hypothesized
that CD11b activation may play a protective role during the
process of calcification. To assess the hypothesis, primary WT
murine chondrocytes were allowed to calcify for 24 h with
CPP in the presence or absence of LA1, and assessed by
Alizarin Red staining. We found that LA1 treatment significantly
reduced chondrocyte mineralization (Figure 4A), without any
associated in vitro cytotoxicity as measured by LDH activity
(Supplementary Figure 3A). Importantly, we also found that
LA1 significantly inhibited IL-6 and MCP-1 secretion in a dose
dependent manner confirming the anti-inflammatory role of
LA1-mediated integrin activation in chondrocytes (Figure 4B).
To further demonstrate that CD11b activation on
chondrocytes prevents cartilage calcification in vitro, we
performed RT-qPCR analysis of the previously investigated genes
related to calcification, differentiation and extracellular matrix
turn-over. In Figure 4D, Anx5 was significantly increased in WT
chondrocytes treated with LA1, compared to control, while Alp
was decreased. This latter modulation is in line with the previous
result in which CD11b KO cells had increased Alp. The genes
Sox9, Col2, Runx2, Col10, Mmp3, Mmp13 and Timp1 were all
decreased with LA1 stimulation. In LA1 treated chondrocytes
without CPP, Adamts5 was significantly increased compared
to control cells (Figure 4C). Furthermore, in Figure 4E, we
investigated Alp activity in WT chondrocytes treated with LA1
or its control, and found that LA1 decreased Alp both with
CPP and without.
To further evaluate the anti-calcifying effect of LA1 on
human cells, we performed Alizarin Red staining on human
primary chondrocytes extracted from damaged cartilage (8
OA patients). LA1 reduced mineralization in six out of eight
primary chondrocyte cultures (Figure 4F). Moreover, in the
same conditions LA1 significantly reduced IL-6 levels in the
supernatant (Figure 4G). Finally, the anti-calcifying property
of LA1 was not restricted to chondrocytes, as LA1 was also
able to inhibit crystal deposition in human primary synoviocytes
purified from OA patient’s synovial membrane (Supplementary
Figure 3B), after calcification induction.
Cartilage Damage and Periarticular
Crystal Deposits Are Exacerbated in
CD11b Deficient Mice Following
Experimental OA
Based on the increased propensity of CD11b-deficient
chondrocytes to mineralize and to produce IL-6 and on the
increased levels of IL-6 produced in vivo (Stevanin et al., 2017),
we hypothesized genetic ablation of CD11b in mice would
predispose these animals to OA.
We analyzed the development of instability-induced OA
changes in CD11b deficient and WT mice using the knee
meniscectomy (MNX) model as previously described (Nasi et al.,
2016b), and sacrifice after 8 weeks from the knee surgery.
Cartilage damage, as evidenced by OARSI scoring of medial tibial
plateau and medial femoral condyle, was significantly increased
in CD11b-deficient mice, with decreased proteoglycans content
(less Safranin-O staining), more fissurations and fibrillations
compared to WT control mice (Figures 5A,B). Moreover, the
joints of CD11b KO mice exhibited significantly increased
synovial inflammation (Figure 5C), and increased, but not
significant, osteophyte formation (Figure 5D) in CD11b KO
mice, with respect to their WT control.
In addition, microCT-scan examination was conducted to
analyze the crystal deposition (Figure 5E). By CT Analyzer
quantification, both the volume of newly formed crystals as well
as the overall crystal content, were slightly increased in CD11b
KO mice compared to WT control, although these differences did
not reach statistical significance (Figure 5F).
In order to rule out an underlying cartilage or bone phenotype
in CD11b KO mice, that may predispose them to OA, we
analyzed cartilage damage and subchondral bone structure in
unchallenged WT and CD11b KO mice. In the first experimental
setting we considered knees from sham-operated 20 weeks old
WT and CD11b KO mice. OARSI scoring revealed no difference
in cartilage degradation between WT and CD11b KO mice
(Supplementary Figures 4A,B). Moreover, no difference was
seen in subchondral bone mineral density and subchondral bone
trabecular thickness (Supplementary Figures 4C,D) between
the two different genotypes. Similar results were obtained in
aged WT and CD11b KO mice (37 weeks old), where no
difference in cartilage damage (Supplementary Figure 4E,F)
nor in subchondral bone parameters was seen (Supplementary
Figures 4G,H).
DISCUSSION
Integrin CD11b/CD18 is a receptor originally described on
neutrophils and macrophages, known to support adhesion and
molecular cross-talk of these cells with the extracellular matrix
proteins. It regulates many functions including phagocytosis,
migration and immune tolerance (Ehirchiou et al., 2007; Rosetti
and Mayadas, 2016), but it can also bind to a great number of
different ligands, among which fibrinogen (Rosetti and Mayadas,
2016), fibronectin and laminin (Bohnsack and Zhou, 1992) can
also be found in cartilage. CD11b/CD18 is generally thought to
be exclusively expressed on leukocytes. In this work, we showed
that CD11b is also expressed on chondrocytes, and importantly,
established a novel role of CD11b integrin signaling in cartilage
calcification and degradation in a mouse model of OA.
We first demonstrated the expression of the CD11b
integrin subunit on primary murine and human chondrocytes
and in articular cartilage of both murine and human OA
patients by combining flow cytometry, qRT-PCR analysis and
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FIGURE 4 | CD11b agonist reduces murine and human chondrocytes calcification in vitro. (A) Alizarin Red staining of WT primary murine chondrocytes stimulated
with secondary CPP ± LA1 (20 µM) for 24 h in DMEM + 10% FBS. Pictures show one representative culture well of one experiment out of three independent
experiments. The graph shows the percentage of Alizarin Red positive surface over the total surface, normalized on Vehicle treated cells. Values represent
means ± SD of triplicates samples. (B) IL-6 and MCP-1 concentration in cell supernatants of WT primary chondrocytes stimulated with secondary CPP and LA1 at
different concentration (0 µM - Vehicle-, 1 µM and 20 µM). Values represent means ± SD of triplicates samples; *p < 0.05, ***p < 0.001. (C) qRT-PCR of the
indicated genes in murine chondrocytes stimulated with LA1 (20 µM) or its vehicle for 4 h. Values represent fold increase of LA1 treated chondrocytes over their
Vehicle-treated cells, shown in means ± SD of triplicates samples; ****p < 0.0001. (D) qRT-PCR of the indicated genes in WT primary murine chondrocytes
stimulated with secondary CPP ± LA1 (20 µM) for 4 h. Values represent fold increase in LA1 treated chondrocytes over Vehicle-treated cells, shown as means ± SD
of triplicates samples; *p < 0.05, ***p < 0.001, ****p < 0.0001. (E) Quantification of Alkaline phosphatase activity in WT chondrocytes treated with secondary
CPP ± LA1 for 6 h. Values represent fold increase of Alp activity in LA1 treated chondrocytes over Vehicle-treated cells treated, shown as means ± SD of triplicates
samples; **p < 0.01. (F) Alizarin Red staining of human primary chondrocytes stimulated with secondary CPP and treated with LA1 or its Vehicle. Pictures show one
representative culture well of one OA patient (P9) out of eight patients. The graph shows the corresponding Alizarin Red positive surface over the total surface,
calculated in Adobe R© Photoshop R©, and then normalized. Lines connect the two conditions for each patient, values are calculated over CPP-Vehicle and represent
means of triplicates samples; *p < 0.05. (G) IL-6 concentration in supernatants of human primary chondrocytes at point (F). Values represent means of triplicates
samples; *p < 0.05.
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FIGURE 5 | Cartilage damage and periarticular crystal deposits are exacerbated in CD11b deficient mice following experimental OA. (A) Representative Safranin-O
histological staining of knee joints from WT and CD11b KO mice 8 weeks after MNX. Black arrows show degenerative OA changes in CD11b KO mice. Scale bars
100 µm. (B) Corresponding total OARSI score for cartilage damage in medial compartment of WT and CD11b KO knees. Values represent means ± SD; **p < 0.01.
(C) Synovial inflammation scoring in WT and CD11b KO MNX mice knees; ***p < 0.001. (D) Osteophyte scoring in WT and CD11b KO MNX mice knees.
(E) Representative micro-CT scan images of murine knee joints from WT and CD11b KO mice of point (A). Red arrows show calcified deposits in meniscectomized
knees. (F) Corresponding CT Analyzer quantitative analysis of new formation volume (TV: tissue volume, mm3) and new formation crystal content (µg) in WT and
CD11b KO menisectomized mice. Data are expressed as the mean ± SD.
immunohistochemistry. CD11b is expressed only on a subset of
chondrocytes in the superficial zone of the articular cartilage,
and by FACS we confirmed 3–4% of chondrocytes expressing
this integrin subunit. In line, in an open access database of single
cell RNA sequencing on human OA chondrocytes (Ji et al.,
2019), the gene encoding for CD11b was expressed in 3.15%
of cells (analysis not shown), and these CD11b expressing cells
also expressed Col2 as a marker of chondrocytes. Our results
are also in agreement with a previous study reporting a very
low expression of β2 integrin on chondrocytes (Iannone et al.,
2001). Surprisingly, we also found CD11b in the extracellular
matrix of cartilage from OA patients. This could be accounted
for by cleavage of the extracellular domain of CD11b from the
cell surface after cell activation under inflammatory conditions.
This cleavage involves matrix metalloproteases and leads to
subsequent binding of cleaved CD11b to extracellular matrix
proteins (Zen et al., 2011). The presence of soluble complexes
of CD11 and CD18 have been reported in human plasma and
in synovial fluid from patients with arthritis (Gjelstrup et al.,
2010). We confirmed the presence of soluble CD11b in the
synovial fluid of OA patients that we analyzed, although cellular
sources and targets of soluble CD11b remain to be determined.
In OA joints, we postulate that the main source could be synovial
cells and infiltrating inflammatory cells such as macrophages
and neutrophils. Indeed, these cells express high levels of
CD11b and inflammation-induced matrix metalloproteases
which could contribute to CD11b shedding (Gjelstrup et al.,
2010; Manferdini et al., 2016). The pathological relevance of
extracellular CD11b is unclear and further investigations will be
needed to determine the contribution of the truncated form of
CD11b on OA progression.
We demonstrated that CD11b KO chondrocytes mineralized
more than WT chondrocytes and that this could be via multiple
mechanisms. First, CD11b KO chondrocytes showed more
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active calcification machinery compared to WT cells. Calcium-
containing crystals, and in particular BCP crystals, are formed
when excess of calcium (Ca2+) and inorganic phosphate (Pi) are
uptaken into matrix vesicles (Anderson et al., 2004; Ea et al.,
2011). Crystal formation starts when inorganic pyrophosphate
(PPi) is extruded extracellularly via the multipass transmembrane
transporter Ank. Extracellular PPi is then hydrolyzed to Pi
by the enzyme tissue-non-specific alkaline phosphatases (Alp).
Finally, Pi is concentrated in matrix vesicles through the
cotransporters Pit1/Pit2 and Ca2+ through annexin 5 (Anx5).
Here we demonstrated that CD11b KO chondrocytes, both at
basal- and CPP-condition, express higher levels of the pro-
mineralizing genes Ank, Alp and Pit1, and have more active
Alp enzyme. Down-regulation of these calcification factors could
be a potential mechanism by which CD11b exerts its anti-
mineralizing properties in chondrocytes. From the literature,
we can speculate possible cross-talks between CD11b-dependent
signaling pathways such as JNK and NF-kB and these calcification
players. Activation of the JNK (Suzuki et al., 2006; Wu et al.,
2016) or of the NF-kB (Koumakis et al., 2019) pathway has
been demonstrated to induce Pit1 expression and subsequent cell
matrix mineralization or inflammation respectively. JNK and NF-
kB activation were also associated to increased Alp expression
and osteoblastic differentiation of arterial smooth muscle cells
(Chang et al., 2020). As a second calcification mechanism, in
our study we found that CD11b deficient chondrocytes secreted
increased amounts of pro-inflammatory and pro-mineralizing
IL-6 and MCP-1 when stimulated with CPP. More importantly,
by blocking the receptor of IL-6 on CD11b KO chondrocytes we
were able to greatly decrease calcification. Another characteristic
of mineralizing chondrocytes is hypertrophy. Indeed, CD11b
deficiency induced considerable upregulation of Col10 and
downregulation of Col2, as shown by the ratio, indicating that
CD11b deficient chondrocytes are in a hypertrophic state. In
summary, we demonstrated that CD11b is an important negative
regulator of mineralization in chondrocytes and most if not all of
its anti-mineralizing effects could be accounted by decreased pro-
mineralizing IL-6 cytokine levels (Nasi et al., 2016b). To address
the underlying mechanisms involved in enhanced cartilage
degradation of CD11b-deficient mice after MNX, we analyzed
the key ECM markers under this disease setting. Surprisingly,
deletion of the CD11b gene did not cause a coordinated increased
expression of enzymes related to ECM degradation, as the pro-
catabolic aggrecanase Adamts4 was upregulated in CD11b KO
chondrocytes concomitantly with its inhibitor Timp3. Another
pro-catabolic metalloprotease Mmp13 was downregulated in
CD11b KO chondrocytes. Upon stimulation with the CD11b
agonist LA1, both Adamts5 and its inhibitor Timp1 were
increased. Given these expression patterns of ECM enzymes,
we ruled out their early modulation as a crucial mechanism
explaining the more severe phenotype observed in CD11b KO
cells and mice, and the in vitro protective effect of LA1.
However, as mentioned above, measurement of the
supernatant from stimulated CD11b KO chondrocytes showed
an increase in both IL-6 and MCP-1 levels, which are known
players in cartilage catabolism, alongside cartilage calcification
(Kapoor et al., 2011; Nasi et al., 2016b).
We found that increased cartilage degradation is associated
with synovial inflammation and the formation of osteophytes in
CD11b KO mice after meniscectomy, while we could rule out that
an underlying pre-existing pathology or bone phenotype exists in
sham-operated knees and knees of old CD11b KO mice, which
may predispose them to OA. Our data suggest that modulating
CD11b could be an effective strategy to protect the cartilage in
experimental OA. A growing body of literature demonstrates the
role of Leukadherin-1 (LA1) mediated activation of CD11b in
regulating inflammation in experimental models of inflammatory
disorders. By binding to an allosteric pocket in the CD11b
subunit, LA1 changes the conformation of the extracellular
domain, thereby preventing infiltration of pro-inflammatory
monocytes after organ injury and vascular dysfunction (Maiguel
et al., 2011; Schmid et al., 2018). In a study by C. Han et al.
(2010), the authors show that CD11b, once activated by Toll-Like
Receptor (TLR), triggers spleen tyrosine kinase (Syk) activation
and phosphorylation of MyD88 and TRIF, which are then
degraded by proteolysis, thereby reducing IL-6, TNF and IFN-
β downstream production. Another study (Faridi et al., 2017)
demonstrated that LA1 activated CD11b which in turn inhibited
MyD88 and TRIF downstream pathway. The effects of LA1 on
chondrocytes have not been studied. Our results demonstrated
the anti-inflammatory effect of LA1 in chondrocytes. Indeed,
we found that WT chondrocytes cultured with LA1 showed
a reduction in calcification and a decrease in production of
the IL-6 and MCP-1. Additionally, we also obtained significant
reduction in calcification and IL-6 release in human chondrocytes
treated with LA1. Finally, as human OA synoviocytes can also
calcify (Sun et al., 2014), we showed that LA1 can decrease
mineralization of these cells, thereby confirming a general anti-
mineralizing effect of LA1. On the other hand, we ruled out
that the anti-mineralizing effect of LA1 was mediated by reduced
chondrocyte hypertrophy, as LA1 suppressed the expression of
both early-stage (Coll2, Sox9) and late-stage hypertrophy (Coll10,
Runx2) chondrocitic markers.
However, we cannot rule out the possibility that LA1 can
block calcification via a CD11b-independent mechanism, which
deserves further investigation.
While a direct association between CD11b and calcification
has not been reported, genome-wide association studies have
established a strong correlation between single-nucleotide
polymorphisms (SNPs) in the ITGAM gene coding for CD11b
and susceptibility to SLE (Hom et al., 2008; Nath et al.,
2008). These SNPs produce a dysfunctional CD11b protein
on leukocytes that is deficient in many functions including
activation, ligand binding, cell adhesion and phagocytosis (Khan
et al., 2018). Moreover, Dahdal et al. reported that SLE patients
have significantly elevated calcification propensity in their serum
(Dahdal et al., 2018). In addition, earlier research has shown a
link between coronary artery calcifications and increased disease
activity in young lupus patients (Romero-Diaz et al., 2012).
Finally, an association between IL-6 and progression of lupus has
been demonstrated using several murine models of SLE (Tang
et al., 1991; Alarcon-Riquelme et al., 1992; Kobayashi et al.,
1992). However, it is still unknown how the SNPs contribute
to the calcification propensity seen in lupus patients. Our data
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suggest a strong direct link between reduced CD11b function and
increased calcification, which can be explained by the inability of
CD11b KO chondrocytes to downregulate the pro-inflammatory
cytokine and chemokine production.
Although the contribution of CD11b integrin in calcification
is clearly established in the present study, we did not investigate
which ligands bind to CD11b in the cartilage. Integrin CD11b is
a multi-ligand receptor capable of binding ICAM-1, fibrinogen,
fibronectin, factor X and complement factor iC3b, among many
others (Rosetti and Mayadas, 2016). Integrin ligands have been
shown to play a crucial role in OA (Pfander et al., 1999;
Pullig et al., 2000). Indeed, previous studies have demonstrated
that following cartilage damage, fragmented extracellular matrix
molecules can trigger catabolic gene expression in various cells
in the joint tissues (Homandberg et al., 2002; Loeser et al., 2003).
Further studies will be required to investigate the contribution of
CD11b ligands in OA cartilage.
Even though our current work unveils a new pathway in OA, it
also presents some limitations that have to be considered. The use
of global CD11b KO mice does not allow us to determine whether
the observed effects are solely due to lack of CD11b expression in
chondrocytes and not due to other cells in the surrounding tissues
of the joint. This question will be resolved in future by generating
mice with a selective CD11b deficiency in cartilage.
In summary, our study showed for the first time that
CD11b signaling plays an important role in regulating cartilage
calcification and OA. Deletion of CD11b gene was linked
with cartilage degradation in knee joints during OA, mediated
by upregulation of the pro-inflammatory IL-6 and MCP-1.
Moreover, activation of CD11b with the LA1 agonist decreased
the levels of pro-inflammatory cytokines and prevented
calcification in vitro. This study offers novel insights into the
role of CD11b integrin signaling in regulatory mechanisms that
control OA severity and progression, and provides a new target
for future therapies, with final aim of improving the quality of
life in OA patients.
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